Ananth Narayanan joins Medlife as co-founder and CEO

Published On 2019-08-06 11:04 GMT   |   Update On 2019-08-06 11:04 GMT

New Delhi: Online health platform Medlife on Monday said former Myntra-Jabong CEO Ananth Narayanan has joined the company as its chief executive officer and co-founder. Narayanan, who has also invested an undisclosed amount in Medlife, will be responsible for driving the next phase of growth of the company that is raising its first external round of funding of USD 150 million.


"Healthcare is a USD 100 billion-plus market opportunity but there is very little technology disruption. Medlife has an interesting interplay in e-pharmacy, e-diagnostics, and e-consultancy which was very interesting for me. I decided to join them because I feel technology can play a disruptive role in making healthcare simple, personal, and accessible to all Indians," Narayanan told.


Narayanan will also join the company's Board of Directors of Medlife, which was founded in November 2014 by Prashant Singh and Tushar Kumar.


Read Also: Improper storage kills shelf life of drugs; Health Ministry raises concern


Medlife has scaled its business to clock Rs 1,000-crore revenue run rate. It currently operates across 4,000 cities and makes over deliveries daily. It operates its medicine delivery service through 40 fulfillment centers and three large regional hubs in 22 cities. Besides, it has one national and five regional laboratories, and over 350 phlebotomists to take diagnostics to patients' homes.


Narayanan said the company is in the midst of fundraising of USD 150 million with participation from strategic and financial investors and is expected to be completed in the next 3-5 months.


Read Also: Medlife acquires medicine delivery startup Myra Medicines

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News